Correspondence 0001493152-23-004580 from Neuraxis, INC (NRXS) (CIK 0001933567) (NRXS)
Neuraxis, INC (NRXS) (CIK 0001933567)
Date: Feb. 14, 2023 · CIK: 0001933567 · Accession: 0001493152-23-004580
AI Filing Summary & Sentiment
File numbers found in text: 333-269179
Show Raw Text
CORRESP
1
filename1.htm
February
14, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention: Cindy
Polynice
Re:
Neuraxis, Inc.
Registration Statement
on Form S-1
Filed February 13, 2023
File No. 333-269179
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Alexander Capital, L.P., as representative
of the several underwriters, hereby joins Neuraxis, Inc., (the “Company”) in requesting that the Securities and Exchange
Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-269179) (the “Registration
Statement”) to become effective on February 14, 2023, at 5:00 pm, Eastern Time, or as soon thereafter as practicable, or at such
other time as the Company or its outside counsel, Lucosky Brookman LLP, request by telephone that such Registration Statement be declared
effective.
The
undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters
and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.
Very truly yours,
ALEXANDER CAPITAL, L.P.
By:
/s/
Jonathan Gazdak
Name:
Jonathan Gazdak
Title:
Managing Director - Head of Investment Banking